J Korean Soc Transplant.
1998 Nov;12(2):241-246.
Mycophenolate Mofetil in Living Donor Renal Allograft Recipients: Prospective Study up to 1 Year Post-transplantation
- Affiliations
-
- 1Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.
- 2Institute for Transplantation Research, Yonsei University College of Medicine, Seoul, Korea.
Abstract
- No abstract available.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Pretransplant mycophenolate mofetil reduces intrahepatic cholangiopathy related to laparoscopic donor hepatectomy in ABO-incompatible liver transplantation
- Mycophenolate Mofetil Versus Azathioprine in Cyclosporine Based Triple Immunosuppression
- Prospective Study of Mycophenolate Mofetil in Living Donor Renal Allograft Recipents
- Prospective Controlled Protocol for Three Months Steroid Withdrawal with Tacrolimus, Basiliximab, and Mycophenolate Mofetil in Renal Transplant Recipients
- Mycophenolate Mofetil in Combination with Tacrolimus in Adult Living Donor Liver Transplant Recipients
